American Portfolios Advisors Cytosorbents Corp Transaction History
American Portfolios Advisors
- $2.36 Trillion
- Q3 2022
A detailed history of American Portfolios Advisors transactions in Cytosorbents Corp stock. As of the latest transaction made, American Portfolios Advisors holds 1,000 shares of CTSO stock, worth $1,500. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,000Holding current value
$1,500% of portfolio
0.0%Shares
8 transactions
Others Institutions Holding CTSO
# of Institutions
55Shares Held
16.9MCall Options Held
10.1KPut Options Held
500-
Avenir Corp Washington, DC2.97MShares$4.46 Million0.21% of portfolio
-
Skylands Capital, LLC2.84MShares$4.26 Million0.3% of portfolio
-
Granahan Investment Management, LLC Waltham, MA2.66MShares$4 Million0.08% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.95MShares$2.92 Million0.0% of portfolio
-
Neuberger Berman Group LLC New York, NY1.54MShares$2.3 Million0.0% of portfolio
About Cytosorbents Corp
- Ticker CTSO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 43,577,400
- Market Cap $65.4M
- Description
- Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...